Vidéos
EditorialFootage by NurPhoto
Contenus
Getty Images
Photos
INA
Contenus
PhotoSport
Photos
RMN-GRAND PALAIS
10/02/2026 12:00
ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases

ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune response...

Bacardi Climbs to #32 Among the World’s Top Companies for Women

Bacardi Limited has climbed to #32 on the Forbes list of the World’s Top Companies for Women 2026, rising from #60 the previous year and earning a place on the prestigious global ranking for the fifth consecutive year. The family-owned company is the highest-ranked spirits company on this year’s list and ranks #2 in the “Food, Soft Beverages, Alcohol & Tobacco” category. The recognition reflects a continued commitment to creating opportunities, championing career development and...
Anglais

Shefali Khan and Aakash Gulzar: Winners of the Marai Photo Grant 2026 Announced

The 2026 Marai Photo Grant winners have been announced.

The 2026 Marai Photo Grant winners have been announced.
Anglais

AFP Honoured at SOPA Awards for Coverage in Bangladesh

AFP was recognised with an Honourable Mention in the Excellence in Breaking News Reporting category at the prestigious Society of Publishers in Asia (SOPA) Awards for its coverage of the revolution in Bangladesh.

AFP was recognised with an Honourable Mention in the Excellence in Breaking News Reporting category at the prestigious Society of Publishers in Asia (SOPA) Awards for its coverage of the revolution in Bangladesh.
10/22/2026 10:18
Spotlight Medical Announces Successful Independent Evaluation of Its Digital Slide-Based Test for Assessing Recurrence Risk in Early Breast Cancer

An independent, blinded evaluation of 620 patients from the phase III PANTHER trial identified nearly one-quarter as Low Risk despite clinically high-risk breast cancer, with favorable ten-year outcomes. Spotlight Medical, a company developing AI-powered prognostic tests in oncology, today announced results from an independent evaluation of myStage Dx, its CE-IVDR-marked test for assessing recurrence risk in patients with hormone receptor-positive, HER2-negative early breast cancer. The study wa...

Subscribe to